Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vericel Corporation
(NQ:
VCEL
)
47.83
-0.05 (-0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vericel Corporation
< Previous
1
2
3
Next >
Analyst Scoreboard: 5 Ratings For Vericel
March 26, 2024
Via
Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
A Closer Look at 4 Analyst Recommendations For Vericel
March 01, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.
Via
InvestorPlace
HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
January 16, 2024
Via
Benzinga
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
Via
Benzinga
Analyst Ratings for Vericel
October 16, 2023
Via
Benzinga
Analyst Ratings for Vericel
September 21, 2023
Via
Benzinga
Expert Ratings for Vericel
August 03, 2023
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.
Via
InvestorPlace
3 Strong Buy Stocks Set to Take Off in the Coming Months
November 10, 2023
These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in?
Via
InvestorPlace
Earnings Scheduled For November 8, 2023
November 08, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via
Benzinga
Vericel: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Vericel Earnings Perspective: Return On Capital Employed
February 28, 2023
Via
Benzinga
Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses
September 20, 2023
J Capital Research has released a short idea report on Vericel Corporation (NASDAQ:
Via
Benzinga
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
Analyst Expectations for Vericel's Future
February 27, 2023
Via
Benzinga
Analyst Ratings for Vericel
January 27, 2023
Via
Benzinga
What's Going On With Vericel Shares Trading Higher
January 10, 2023
Vericel Corp (NASDAQ: VCEL) shares are trading higher by 13.63% to $27.10 Tuesday after the company reported preliminary FY22 revenue results. What Else?
Via
Benzinga
FDA Approves MediWound's NexoBrid For Burn Treatment
December 30, 2022
Via
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) may have had a successful year of novel drug development.
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
Looking Into Vericel's Return On Capital Employed
December 14, 2022
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.